Login / Signup
Shuhei Okuyama
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 3
Top Topics
Mouse Model
Drug Release
Photodynamic Therapy
Fluorescence Imaging
Top Venues
Molecular cancer therapeutics
Cancer immunology research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Hiroshi Fukushima
,
Aki Furusawa
,
Takuya Kato
,
Hiroaki Wakiyama
,
Seiichiro Takao
,
Shuhei Okuyama
,
Peter C Black
,
Hisataka Kobayashi
Intratumoral interleukin-15 improves efficacy of near-infrared photoimmunotherapy.
Molecular cancer therapeutics
(2023)
Hiroaki Wakiyama
,
Takuya Kato
,
Aki Furusawa
,
Ryuhei Okada
,
Fuyuki F Inagaki
,
Hideyuki Furumoto
,
Hiroshi Fukushima
,
Shuhei Okuyama
,
Peter C Black
,
Hisataka Kobayashi
Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy.
Cancer immunology research
10 (11) (2022)
Takuya Kato
,
Aki Furusawa
,
Ryuhei Okada
,
Fuyuki F Inagaki
,
Hiroaki Wakiyama
,
Hideyuki Furumoto
,
Hiroshi Fukushima
,
Shuhei Okuyama
,
Peter C Black
,
Hisataka Kobayashi
Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts.
Molecular cancer therapeutics
(2022)